Drug Trial Radar · NCT02734537
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
189
Planned (sponsor's estimate)
Start
Nov 23, 2016
Primary completion
Dec 31, 2027
Study completion Dec 31, 2027
Sponsor
- Lead sponsor
- ECOG-ACRIN Cancer Research GroupResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Apr 12, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase II trial studies how well radiation therapy with or without cisplatin works in treating patients with stage III-IVA squamous cell carcinoma of the head and neck who have undergone surgery. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Drugs used in chemotherapy, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known if radiation therapy is more effective with or without cisplatin in treating patients with squamous cell carcinoma of the head and neck.
Conditions
- Head and Neck Squamous Cell Carcinoma
- Hypopharyngeal Squamous Cell Carcinoma
- Laryngeal Squamous Cell Carcinoma
- Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant
- Lip and Oral Cavity Squamous Cell Carcinoma
- p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma
- Stage III Hypopharyngeal Carcinoma AJCC v8
- Stage III Laryngeal Cancer AJCC v8
- Stage III Lip and Oral Cavity Cancer AJCC v8
- Stage III Oral Cavity Verrucous Carcinoma
- Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Stage IVA Hypopharyngeal Carcinoma AJCC v8
- Stage IVA Laryngeal Cancer AJCC v8
- Stage IVA Lip and Oral Cavity Cancer AJCC v8
- Stage IVA Oral Cavity Verrucous Carcinoma
- Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Interventions
CisplatinDrug
Given IV
Intensity-Modulated Radiation TherapyRadiation
Undergo IMRT
Laboratory Biomarker AnalysisOther
Correlative studies
Primary outcomes
What the sponsor says the trial is designed to measure.
- Disease-free survival in patients with stage III-IV disease and disruptive p53 mutationTime frame: Date of randomization to the date of recurrence, second primary tumor from the head and neck region, or death, assessed up to 10 years
Locations
679 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama · Active not recruiting
Anchorage Associates in Radiation Medicine
Anchorage, Alaska · Recruiting
Anchorage Radiation Therapy Center
Anchorage, Alaska · Suspended
Alaska Breast Care and Surgery LLC
Anchorage, Alaska · Recruiting
Alaska Oncology and Hematology LLC
Anchorage, Alaska · Recruiting
Alaska Women's Cancer Care
Anchorage, Alaska · Recruiting
Anchorage Oncology Centre
Anchorage, Alaska · Suspended
Katmai Oncology Group
Anchorage, Alaska · Recruiting
Providence Alaska Medical Center
Anchorage, Alaska · Recruiting
Fairbanks Memorial Hospital
Fairbanks, Alaska · Recruiting
Cancer Center at Saint Joseph's
Phoenix, Arizona · Recruiting
University of Arizona Cancer Center-Orange Grove Campus
Tucson, Arizona · Suspended
Banner University Medical Center - Tucson
Tucson, Arizona · Recruiting
University of Arizona Cancer Center-North Campus
Tucson, Arizona · Recruiting
Mercy Hospital Fort Smith
Fort Smith, Arkansas · Recruiting
CHI Saint Vincent Cancer Center Hot Springs
Hot Springs, Arkansas · Suspended
CARTI Cancer Center
Little Rock, Arkansas · Recruiting
Mission Hope Medical Oncology - Arroyo Grande
Arroyo Grande, California · Recruiting
Providence Saint Joseph Medical Center/Disney Family Cancer Center
Burbank, California · Recruiting
Mercy Cancer Center - Carmichael
Carmichael, California · Recruiting
Mercy San Juan Medical Center
Carmichael, California · Recruiting
Mercy Cancer Center - Elk Grove
Elk Grove, California · Recruiting
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Irvine, California · Recruiting
UC San Diego Moores Cancer Center
La Jolla, California · Active not recruiting
Mercy Cancer Center
Merced, California · Recruiting
UC Irvine Health/Chao Family Comprehensive Cancer Center
Orange, California · Recruiting
Desert Regional Medical Center
Palm Springs, California · Active not recruiting
Mercy Cancer Center - Rocklin
Rocklin, California · Recruiting
Mercy Cancer Center - Sacramento
Sacramento, California · Recruiting
Pacific Central Coast Health Center-San Luis Obispo
San Luis Obispo, California · Recruiting
Mission Hope Medical Oncology - Santa Maria
Santa Maria, California · Recruiting
Saint Joseph's Medical Center
Stockton, California · Recruiting
Woodland Memorial Hospital
Woodland, California · Recruiting
Penrose-Saint Francis Healthcare
Colorado Springs, Colorado · Recruiting
Rocky Mountain Cancer Centers-Penrose
Colorado Springs, Colorado · Recruiting
Saint Francis Cancer Center
Colorado Springs, Colorado · Recruiting
AdventHealth Porter
Denver, Colorado · Suspended
CommonSpirit Cancer Center Mercy
Durango, Colorado · Recruiting
Mercy Medical Center
Durango, Colorado · Recruiting
Mountain Blue Cancer Care Center
Golden, Colorado · Suspended
Showing 40 of 679 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.